Skip to content
healthcare.dev

Dasatinib

NDC 68001-660, dasatinib, tablet, film coated, from BluePoint Laboratories.

Product NDC
68001-660
Status
Listed
Labeler
BluePoint Laboratories
Dosage form
TABLET, FILM COATED
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA217217
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/68001-660 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • DASATINIB20 mg/1

Pharmacologic classes

Cytochrome P450 3A4 Inhibitors [MoA]; Kinase Inhibitor [EPC]; Protein Kinase Inhibitors [MoA]

Package NDCNDC-11Package
68001-660-066800106600660 TABLET, FILM COATED in 1 BOTTLE (68001-660-06)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/02b04c6f-4ea5-4fcb-bf6d-2631d5ab31e4

Use it

Look up 68001-660 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/68001-660 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 68001-660. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.